Phibro Animal Health (PAHC) Cash & Equivalents Growth (3y) (2016 - 2026)
Powered by 
Analysis
Phibro Animal Health (PAHC) Cash & Equivalents Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.51 Bn | 40.32 Bn | 779.09 Mn | 14.02% |
| 2 | Zoetis | 30.62 Bn | 28.94 Bn | 1.05 Bn | -4.92% |
| 3 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | 13.03% |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | 14.16% |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | 82.64% |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - | 73.01% |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 777.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.16% |
| Mar 31, 2026 | 13.83% |
| Dec 31, 2025 | -6.75% |
| Sep 30, 2025 | -1.56% |
| Jun 30, 2025 | -2.87% |
| Mar 31, 2025 | -5.16% |
| Dec 31, 2024 | 1.90% |
| Sep 30, 2024 | 7.98% |
| Jun 30, 2024 | 12.04% |
| Mar 31, 2024 | 0.76% |
| Dec 31, 2023 | -1.53% |
| Sep 30, 2023 | 11.69% |
| Jun 30, 2023 | 4.34% |
| Mar 31, 2023 | 11.66% |
| Dec 31, 2022 | 37.74% |
| Sep 30, 2022 | 11.59% |
| Jun 30, 2022 | 8.85% |
| Mar 31, 2022 | 25.40% |
| Dec 31, 2021 | 26.47% |
| Sep 30, 2021 | 16.77% |